Physician profile
Sonny Patel
NPI 1417606864
$748.66
in general payments reported to CMS, 2019-2025
9 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $274 · 2023: $74.76 · 2024: $146 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $328.57 | 2022-2024 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $97.05 | 2025 | Rexulti |
| Almatica Pharma LLC | $96.49 | 2024-2025 | Loreev Xr |
| Vanda Pharmaceuticals INC. | $76.66 | 2024-2025 | Fanapt, Hetlioz |
| Bolton Medical INC | $50.73 | 2023 | Treo Abdominal Stent-Graft System |
| Corium, LLC | $27.00 | 2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $25.73 | 2025 | Trintellix |
| Bioxcel Therapeutics, INC. | $24.03 | 2023 | Igalmi |
| Idorsia Pharmaceuticals US INC | $22.40 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonny Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.